Cowin Capital

Cowin Capital is a veteran Shenzhen-based venture firm with a long history in Chinese technology investing and a particular comfort backing hardware-enabled healthcare companies, including medical device manufacturers and connected digital health platforms. The Shenzhen location is structurally important: the city’s hardware supply chain, contract manufacturing depth, and engineering talent pool make it the natural home for medical device companies that need to move from prototype to scaled production efficiently. Limited public information about specific healthcare-focused partner coverage and detailed recent portfolio composition is available in English-language sources, but the firm is one of the more established names in the local venture ecosystem.

Check sizes range from 1 million to 5 million dollars at Series A and Series B, sized to support clinical validation, regulatory submissions, and initial commercial launches for medical device and digital health companies. Geography centers on China with Shenzhen as the base, and the firm’s reach extends across the Pearl River Delta hardware corridor. Companies building outside the Chinese hardware and medical device ecosystem will not find a natural alignment.

The approach is well suited to hardware-anchored medical device founders who want investors fluent in supply chain, contract manufacturing, and NMPA regulatory pathways. Those building software-only digital health businesses without a hardware angle, or companies focused exclusively on Western markets, should weigh whether Cowin’s Shenzhen-rooted value adds enough. Initial conversations should cover the company’s manufacturing plan, regulatory roadmap, and what specific operational support the firm offers around supply chain partners, factory introductions, and downstream syndicate construction at Series B and beyond.